Danish Bactolife A/S grabs funding
Swedish food and feed supplement specialist Bactolife A/S has received US$5m in funding from the Bill & Melinda Gates Foundation to address gastrointestinal infections.
Moderna launches patent dispute with BioNTech/Pfizer
For the second time within a short period of time, a competitor has sued the mRNA vaccine developer BioNtechPfizer for patent infringement.
Belgian eTheRNA raises 39m in Series B2 financing
Moderna co-founder Kenneth Chien and Novalis LifeSciences LLC are the lead investors of a 39m Series B2 financing in eTheRNA.
Kinarus announces CHF 20 million convertible bond issue
Kinarus Therapeutics Holding AG has raised US$20m in financing through the issuance of convertible bonds to YA II PN, Ltd.
Cancer: Western life style is a killer
A study in the scientific journal The Lancet shows that half of all global cancer deaths are due to life style-related risk factors such as smoking and alcohol use.
Ryvu Therapeutics bags 22m from EIB
Polish cancer drug developer, Ryvu Therapeutics, has received 22m funding from the European Investment Bank via its venture debt instrument.
Largest beer brewer to use sustainable PEF bottles
Avantium and AmBev, part of AB InBev Group, have inked an agreement on PEF for soft drink bottles.
Vector Biopharma kicks of with CHF30m Series A financing
With a Series A funding of CHF 30m from Versant Ventures, Vector Biopharma AG set out to solve several of the current gene delivery problems.
Two deaths with Novartis gene therapy
Swiss-headquarterd Novartis AG has reported two cases of fatal liver failure after treatment with the gene therapy Zolgensma.
Azenta set to acquire B Medical Systems
Azenta Inc has entered into an agreement to acquire B Medical Systems S.á r.l. and its subsidiaries for 410m.